This content is from: Premium Glenview Liquidates a Long-Held Major Holding Larry Robbins’ firm disclosed several big moves in its second-quarter 13F document. By Stephen Taub August 12, 2022
Sponsored Valeant Looks To Refinance Loans Valeant Pharmaceuticals International Inc. is seeking to refinance the existing senior secured credit facilities of its wholly owned subsidiary Valeant Pharmaceuticals International. September 21, 2011
This content is from: Portfolio Valeant Pharmaceuticals' Acquisitions Should Please Jeff Ubben Valeant Pharmaceuticals' share price has quadrupled since 2008 thanks to its growth-by-acquisition strategy. By Stephen Taub September 04, 2012
Sponsored Valeant To Buy PharmaSwiss For €350M Canadian specialty pharmaceutical company, Valeant Pharmaceuticals International, will acquire PharmaSwiss for €350 million. February 02, 2011
Sponsored Valeant Offers $5.7B For Cephalon Ontario-based Valeant Pharmaceuticals International is seeking to acquire drug maker, Cephalon, for nearly $5.7 billion. March 29, 2011
Sponsored Valeant Offers $650M In Senior Notes Valeant Pharmaceuticals International has issued $650 million of senior unsecured notes. February 04, 2011
